Firmoscan
Active12798969Private limited companyUxbridge

OXULAR ACQUISITIONS LIMITED

Significant control: Oxular Limited (75–100%), Regeneron Pharmaceuticals, Inc (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Oxular Acquisitions Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Oxular Acquisitions Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

OXULAR ACQUISITIONS LIMITED is an active private limited company (company number 12798969) incorporated on 7 August 2020, registered in Uxbridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (micro entity) but not yet parsed into this record.

There are 151 companies in research and experimental development on biotechnology in Greater London with filed accounts; the median reports net assets of £200 and is 8 years old.

02

Ownership and control

2 active
  • Oxular Limited
    corporate entity, England And Wales · since 7 August 2020
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Regeneron Pharmaceuticals, Inc
    corporate entity, United States · since 20 December 2024
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
7 August 20206 yrs ago
First accounts due
7 May 20221633 days overdue
Confirmation statement due
21 August 2027in 299 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
Accounts type
Micro Entity
05

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

06

Filing and accounts signals

Facts from the register · no rating
  • Incorporated five or more years agoIncorporated 7 August 2020
  • Accounts past their due dateDue 7 May 2022

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 299 days
  2. First accounts due1633 days overdue
  3. Incorporated
08

Similar companies in Greater London

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 7 August 2020 · in Aug 2020.

09

Reminders for OXULAR ACQUISITIONS LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.

This information comes from public filings and our automated processing of them. It may contain errors, be incomplete or be out of date, and is not advice or a credit reference. Check the official record before relying on it. Terms · Privacy · Report an error (corrected within one working day).